# The Swedish BioFINDER - Primary Care Study

> **NCT06120361** · — · RECRUITING · sponsor: **Skane University Hospital** · enrollment: 1200 (estimated)

## Conditions studied

- Mild Dementia
- Mild Cognitive Impairment
- SCD
- Alzheimer Disease
- Lewy Body Disease
- Frontotemporal Degeneration
- Vascular Dementia

## Interventions

- **DIAGNOSTIC_TEST:** Plasma APS 2 score
- **DIAGNOSTIC_TEST:** Plasma p-tau217/np-tau217
- **DIAGNOSTIC_TEST:** Plasma p-tau217
- **DIAGNOSTIC_TEST:** Plasma neurofilament light (NfL)
- **DIAGNOSTIC_TEST:** Plasma Ab42/Ab40
- **DIAGNOSTIC_TEST:** MRI and CT of the brain
- **DIAGNOSTIC_TEST:** Different cognitive tests

## Key facts

- **NCT ID:** NCT06120361
- **Lead sponsor:** Skane University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06120361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06120361, "The Swedish BioFINDER - Primary Care Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06120361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*